Press "Enter" to skip to content

Patent delisted for Allergan drug SANCTURA XR

0
Copyright © DrugPatentWatch. Originally published at Patent delisted for Allergan drug SANCTURA XR

Annual Drug Patent Expirations for SANCTURA+XR
Sanctura Xr is a drug marketed by Allergan and is included in one NDA. There are five patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for SANCTURA XR.

This drug has thirteen patent family members in eleven countries.

The generic ingredient in SANCTURA XR is trospium chloride. Additional details are available on the trospium chloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at Patent delisted for Allergan drug SANCTURA XR
    Do NOT follow this link or you will be banned from the site!